GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE1859.90-29.3 (-1.55 %)
PREV CLOSE ( ) 1889.20
OPEN PRICE ( ) 1856.90
BID PRICE (QTY) 1859.00 (1)
OFFER PRICE (QTY) 1867.00 (25)
VOLUME 3765
TODAY'S LOW / HIGH ( )1846.25 1879.15
52 WK LOW / HIGH ( )1228 2649.95
NSE1871.20-16.95 (-0.9 %)
PREV CLOSE( ) 1888.15
OPEN PRICE ( ) 1878.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 49204
TODAY'S LOW / HIGH( ) 1854.00 1878.20
52 WK LOW / HIGH ( )1227 2524
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax8414.9424756.487230.956472.466539.70
Adjustment-400.03-16364.84-256.41131.71-313.63
Changes In working Capital-457.461198.72457.46440.68-41.93
Cash Flow after changes in Working Capital7557.469590.367432.007044.856184.14
Cash Flow from Operating Activities4842.258107.485779.114905.004094.87
Cash Flow from Investing Activities8078.51-4055.084180.26-568.43-1534.53
Cash Flow from Financing Activities-15433.23-5242.42-6955.60-4276.22-3583.59
Net Cash Inflow / Outflow-2512.46-1190.023003.7860.35-1023.25
Opening Cash & Cash Equivalents2861.874051.891048.12987.772011.02
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent349.412861.874051.891048.12987.77

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.